Status:
COMPLETED
Genomic Study in Non-small Cell Lung Cancer Brain Metastasis
Lead Sponsor:
National Cheng-Kung University Hospital
Conditions:
NSCLC Stage IV
Brain Metastases
Eligibility:
All Genders
Brief Summary
The investigators collected the data from the investigators' center between January 2011 and October 2020. The study included all non-small cell lung cancer patients with surgically excised brain meta...
Detailed Description
The investigators collected the data from from the investigators' center between January 2011 and October 2020. The study included all non-small cell lung cancer patients with surgically excised brain...
Eligibility Criteria
Inclusion
- \- patients diagnosed with non-small cell lung cancer who underwent craniectomy and subsequent whole brain radiotherapy and associated chemo or target therapy
Exclusion
- patient who did not receive postoperative adjuvant therapy
Key Trial Info
Start Date :
January 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 31 2022
Estimated Enrollment :
110 Patients enrolled
Trial Details
Trial ID
NCT04745715
Start Date
January 1 2011
End Date
October 31 2022
Last Update
April 4 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cheng Kung University hospital
Tainan, Taiwan